Suppr超能文献

组织型纤溶酶原激活剂在动脉导管重塑中的作用。

Role of Tissue-Type Plasminogen Activator in Remodeling of the Ductus Arteriosus.

作者信息

Saito Junichi, Ishikawa Yoshihiro, Yokoyama Utako

机构信息

Cardiovascular Research Institute, School of Medicine, Yokohama City University Yokohama Japan.

Department of Cardiovascular Medicine, School of Medicine, Yale University New Haven, CT USA.

出版信息

Circ Rep. 2020 Mar 28;2(4):211-217. doi: 10.1253/circrep.CR-20-0015.

Abstract

Vascular remodeling (e.g., intimal thickening) is necessary for complete closure of the ductus arteriosus (DA). Smooth muscle cells are reported to contribute to DA remodeling. In contrast, the contribution of endothelial cells remains largely unknown. Recent data showed that tissue-type plasminogen activator (t-PA) was highly expressed in the endothelial cells of rat and human DA. It is well known that t-PA is an activator of the blood fibrinolytic system, but t-PA-induced localized proteolysis has been reported to play an important role in vascular development. We found that t-PA-induced plasminogen-plasmin conversion promoted matrix metalloproteinase-2 activation in endothelial cells of rat DA. Gelatinase activity was noted at the internal elastic laminae (IEL) of rat and human DA on in situ gelatin zymography. The in vivo injection of plasminogen to pre-term rats increased gelatinase activation, IEL disruption, and the subsequent intimal thickening formation in the pre-term rat DA. Human DA results partly supported the rat DA findings, suggesting that t-PA-mediated DA remodeling may also be present in the human DA. Current pharmacotherapy for patent DA (PDA) mainly focuses on increasing vascular constriction. Elucidating the molecular mechanisms of DA remodeling may help to expand the range of therapeutic strategies for PDA.

摘要

血管重塑(如内膜增厚)是动脉导管(DA)完全闭合所必需的。据报道,平滑肌细胞有助于DA重塑。相比之下,内皮细胞的作用在很大程度上仍不清楚。最近的数据显示,组织型纤溶酶原激活剂(t-PA)在大鼠和人类DA的内皮细胞中高度表达。众所周知,t-PA是血液纤溶系统的激活剂,但据报道,t-PA诱导的局部蛋白水解在血管发育中起重要作用。我们发现,t-PA诱导的纤溶酶原-纤溶酶转化促进了大鼠DA内皮细胞中基质金属蛋白酶-2的激活。在原位明胶酶谱分析中,在大鼠和人类DA的内弹性膜(IEL)处发现了明胶酶活性。给早产大鼠体内注射纤溶酶原会增加明胶酶激活、IEL破坏以及早产大鼠DA中随后的内膜增厚形成。人类DA的结果部分支持了大鼠DA的研究结果,表明t-PA介导的DA重塑也可能存在于人类DA中。目前针对动脉导管未闭(PDA)的药物治疗主要集中在增加血管收缩。阐明DA重塑的分子机制可能有助于扩大PDA治疗策略的范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/031f/7921361/475799426f9c/circrep-2-211-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验